Increased impulsive behavior and risk proneness following lentivirus-mediated dopamine transporter over-expression in rats' nucleus accumbens

Neuroscience

Volumn 159, Issue 1, 2009, Pages 47-58

  Adriani, W ^a   Boyer, F ^b   Gioiosa, L ^a   Macri S ^a   Dreyer, J L ^b   Laviola, G ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

dopamine transporter; intolerance to delay; probabilistic delivery; sensation seeking

Indexed keywords

DOPAMINE TRANSPORTER; GREEN FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONTROL GROUP; CONTROLLED STUDY; IMPULSIVENESS; LENTIVIRINAE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PRIORITY JOURNAL; RAT; SELF CONTROL;

ANALYSIS OF VARIANCE; ANIMALS; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; IMPULSIVE BEHAVIOR; LENTIVIRUS; MALE; MUTATION; NUCLEUS ACCUMBENS; PROBABILITY; RATS; RATS, WISTAR; REWARD; RISK-TAKING; RNA, MESSENGER; RNA, SMALL INTERFERING; STATISTICS AS TOPIC;

EID: 60349120174     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.11.042     Document Type: Article

References (72)

1. Adriani W., Caprioli A., Granstrem O., Carli M., and Laviola G. The spontaneously hypertensive-rat as an animal model of ADHD: evidence for impulsive and non-impulsive subpopulations. Neurosci Biobehav Rev 27 (2003) 639-651
2. Adriani W., Rea M., Baviera M., Invernizzi W., Carli M., Ghirardi O., Caprioli A., and Laviola G. Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats. Psychopharmacology 176 (2004) 296-304
3. Adriani W., and Laviola G. Delay aversion but preference for binge and rare rewards in two choice tasks: Implications for measuring of self-control parameters. BMC Neurosci 7 (2006) 52
4. Adriani W., Canese R., Podo F., and Laviola G. Reduced impulsive behavior and 1H MRS detectable metabolic brain changes in adult rats exposed to methylphenidate during adolescence. Neurotoxicol Teratol 29 (2007) 116-125
5. Adriani W., and Laviola G. Animal models and mechanisms of impulsivity during adolescence. In: Palomo T. (Ed). Cerebro y mente, Part 3-The affective status and impulsive, motor & motivational symptoms (2009) 385-434 In press
6. Arnett J. Reckless behavior in adolescence: A developmental perspective. Dev Rev 12 (1992) 339-373
7. Bahi A., Boyer F., Gumy C., Kafri T., and Dreyer J.L. In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administration. Eur J Neurosci 20 (2004) 3473-3488
8. Bahi A., Boyer F., Kafri T., and Dreyer J.L. CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirus. Eur J Neurosci 19 (2004) 1621-1633
9. Bahi A., Boyer F., Bussard G., and Dreyer J.L. Silencing dopamine D3-receptor in the nucleus accumbens shell in vivo induces behavioral changes in cocaine-induced hyperlocomotion. Eur J Neurosci 21 (2005) 3415-3426
10. Bahi A., Boyer F., Kolira M., and Dreyer J.L. In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behavior. J Neurochem 92 (2005) 1243-1255
11. Bannon M.J. The dopamine transporter: role in neurotoxicity and human disease. Toxicol Appl Pharmacol 204 (2005) 355-360
12. Barbelivien A., Billy E., Lazarus C., Kelche C., and Majchrzak M. Rats with different profiles of impulsive choice behavior exhibit differences in responses to caffeine and d-amphetamine and in medial prefrontal cortex 5-HT utilization. Behav Brain Res 187 (2008) 273-283
13. Bardo M.T., Bowling S.L., Robinet P.M., Rowlett J.K., Lacy M., and Mattingly B.A. Role of dopamine D1 and D2 receptors in novelty-maintained place preference. Exp Clin Psychopharmacol 1 (1993) 101-109
14. Bardo M.T., Donohew R.L., and Harrington N.G. Psychobiology of novelty seeking and drug seeking behavior. Behav Brain Res 77 (1996) 23-43
15. Biederman J. Attention-deficit/hyperactivity disorder: a life-span perspective. J Clin Psychiatry 59 S7 (1998) 4-16
16. Black D.W., and Moyer T. Clinical features and psychiatric comorbidity of subjects with pathological gambling behavior. Psychiatr Serv 49 (1998) 1434-1439
17. Blaszczynski A., Steel Z., and McConaghy N. Impulsivity in pathological gambling: the antisocial impulsivist. Addiction 92 (1997) 75-87
18. Boyer F., and Dreyer J.L. The role of gamma-synuclein in cocaine-induced behaviour in rats. Eur J Neurosci 27 (2008) 2938-2951
19. Cardinal R.N., Robbins T.W., and Everitt B.J. The effects of d-amphetamine, chlor-diazepoxide, alpha-flupenthixol and behavioural manipulations on choice of a signalled and unsignalled delayed reinforcement in rats. Psychopharmacology 152 (2000) 362-375
20. Cardinal R.N., Parkinson J.A., Hall J., and Everitt B.J. Emotion and motivation: The role of the amygdala, ventral striatum, and prefrontal cortex. Neurosci Biobehav Rev 26 (2002) 321-352
21. Cardinal R.N., Winstanley C.A., Robbins T.W., and Everitt B.J. Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci 1021 (2004) 33-50
22. Cardinal R.N., and Cheung T.H.C. Nucleus accumbens core lesions retard instrumental learning and performance with delayed reinforcement in the rat. BMC Neurosci 6 (2005) 9
23. Cardinal R.N., and Howes N.J. Effects of lesions of the nucleus accumbens core on choice between small certain rewards and large uncertain rewards in rats. BMC Neurosci 6 (2005) 37
24. Casey B.J., and Durston S. From behavior to cognition to the brain and back: What have we learned from functional imaging studies of attention deficit hyperactivity disorder?. Am J Psychiatry 163 (2006) 957-960
25. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 (2003) 386-389
26. Castellanos F.X., Sonuga-Barke E.J., Milham M.P., and Tannock R. Characterizing cognition in ADHD: beyond executive dysfunction. Trends Cogn Sci 10 (2006) 117-123
27. Chambers R.A., and Potenza M.N. Neurodevelopment, impulsivity, and adolescent gambling. J Gambl Stud 19 (2003) 53-84
28. Chau D.T., Roth R.M., and Green A.I. The neural circuitry of reward and its relevance to psychiatric disorders. Curr Psychiatry Rep 6 (2004) 391-399
29. Christakou A., Robbins T.W., and Everitt B.J. Prefrontal cortical-ventral striatal interactions involved in affective modulation of attentional performance: implications for corticostriatal circuit function. J Neurosci 24 (2004) 773-780
30. Comings D.E., Gonzalez N., Wu S., Gade R., Muhleman D., Saucier G., Johnson P., Verde R., Rosenthal R.J., Lesieur H.R., Rugle L.J., Miller W.B., and MacMurray J.P. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet 88 (1999) 358-368
31. Dougherty D.D., Bonab A.A., Spencer T.J., Rauch S.L., Madras B.K., and Fischman A.J. Dopamine transporter density in patients of attention deficit hyperactivity disorder. Lancet 354 (1999) 2132-2133
32. Doyle A.E. Executive functions in attention-deficit/hyperactivity disorder. J Clin Psychiatry 67 (2006) 21-26
33. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Bennett E.R., Nemanov L., Katz M., and Belmaker R.H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12 (1996) 78-80
34. Evenden J.L., and Ryan C.N. The pharmacology of impulsive behaviour in rats: the effects of drugs on response choice with varying delays of reinforcement. Psychopharmacology 128 (1996) 161-170
35. Evenden J.L. Varieties of impulsivity. Psychopharmacology 146 (1999) 348-361
36. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., and Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1313-1323
37. Fischman A.J., Bonab A.A., Babich J.W., Palmer E.P., Alpert N.M., Elmaleh D.R., Callahan R.J., Barrow S.A., Graham W., Meltzer P.C., Hanson R.N., and Madras B.K. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters. Synapse 29 (1998) 128-141
38. Gainetdinov R.R., and Caron M.G. Genetics of childhood disorders: XXIV. ADHD, part 8: hyperdopaminergic mice as an animal model of ADHD. J Am Acad Child Adolesc Psychiatry 40 (2001) 380-382
39. Hironaka N., Ikeda K., Sora I., Uhl G.R., and Niki H. Food-reinforced operant behavior in dopamine transporter knockout mice: enhanced resistance to extinction. Ann N Y Acad Sci 1025 (2004) 140-145
40. Hollander E., Buchalter A.J., and DeCaria C.M. Pathological gambling. Psychiatr Clin North Am 23 (2000) 629-642
41. Hollander E., Sood E., Pallanti S., Baldini-Rossi N., and Baker B. Pharmacological treatments of pathological gambling. J Gambl Stud 21 (2005) 99-110
42. Jucaite A., Fernell E., Halldin C., Forssberg H., and Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 57 (2005) 229-238
43. Laucht M., Becker K., El-Faddagh M., Hohm E., and Schmidt M.H. Association of the DRD4 exon III polymorphism with smoking in fifteen-year-olds: a mediating role for novelty seeking?. J Am Acad Child Adolesc Psychiatry 44 (2005) 477-484
44. Laviola G., Macri S., Morley-Fletcher S., and Adriani W. Risk-taking behavior in adolescent mice: Psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev 27 (2003) 19-31
45. Lowengrub K., Iancu I., Aizer A., Kotler M., and Dannon P.N. Pharmacotherapy of the pathological gambling: review of new treatment modalities. Expert Rev Neurother 6 (2006) 1845-1851
46. Madras B.K., Miller G.M., and Fischman A.J. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1397-1409
47. Maggos C.E., Spangler R., Zhou Y., Schlussman S.D., Ho A., and Kreek M.J. Quantitation of dopamine transporter mRNA in the rat brain: mapping, effects of "binge" cocaine administration and withdrawal. Synapse 26 (1997) 55-61
48. Mazei-Robinson M.S., and Blakely R.D. ADHD and the dopamine transporter: are there reasons to pay attention?. Handb Exp Pharmacol 175 (2006) 373-415
49. Nordin C., and Nylander P.O. Temperament and character in pathological gambling. J Gambl Stud 23 (2007) 113-120
50. Oades R.D. Frontal, temporal and lateralized brain function in children with attention-deficit hyperactivity disorder: a psychophysiological and neuropsychological viewpoint on development. Behav Brain Res 94 (1998) 83-95
51. Petry N.M. Pathological gamblers, with and without substance use disorders, discount delayed rewards at high rates. J Abnorm Psychol 110 (2001) 482-487
52. Piazza P.V., Maccari S., Deminiere J.M., Le Moal M., Mormede P., and Simon H. The corticosterone levels determine individual vulnerability to amphetamine self-administration. Proc Natl Acad Sci U S A 88 (1991) 2088-2092
53. Rebec G.V., Christiansen J.R.C., Guerra C., and Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res 776 (1997) 61-67
54. Rebec G.V., Grabner C.P., Johnson M., Pierce R.C., and Bardo M.T. Transient increases in cathecolaminergic activity in medial prefrontal cortex and nucleus accumbens shell during novelty. Neuroscience 76 (1997) 707-714
55. Rodriguez-Jimenez R., Avila C., Jimenez-Arriero M.A., Ponce G., Monasor R., Jimenez M., Aragües M., Hoenicka J., Rubio G., and Palomo T. Impulsivity and sustained attention in pathological gamblers: influence of childhood ADHD history. J Gambl Stud 22 (2006) 451-461
56. Russell V.A., Sagvolden T., and Johansen E.B. Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 15 (2005) 1-9
57. Sagvolden T., Russell V.A., Aase H., Johansen E.B., and Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 57 (2005) 1239-1247
58. Sagvolden T., and Sergeant J.A. Attention deficit/hyperactivity disorder-from brain dysfunctions to behaviour. Behav Brain Res 94 (1998) 1-10
59. Salamone J.D., and Correa M. Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137 (2002) 3-25
60. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 (1997) 1593-1599
61. Seeman P., and Madras B.K. Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 3 (1998) 386-396
62. Snyder R., Turgay A., Aman M., Binder C., Fisman S., Carroll A., and Risperidone Conduct Study Group. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 41 (2002) 1026-1036
63. Sonuga-Barke E.J. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways. Biol Psychiatry 57 (2005) 1231-1238
64. Sood E.D., Pallanti S., and Hollander E. Diagnosis and treatment of pathologic gambling. Curr Psychiatry Rep 5 (2003) 9-15
65. Specker S.M., Carlson G.A., Christenson G.A., and Marcotte M. Impulse control disorders and attention deficit disorder in pathological gamblers. Ann Clin Psychiatry 7 (1995) 175-179
66. Spencer T.J., Biederman J., Madras B.K., Faraone S.V., Dougherty D.D., Bonab A.A., and Fischman A.J. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 57 (2005) 1293-1300
67. Steel Z., and Blaszczynski A. Impulsivity, personality disorders and pathological gambling severity. Addiction 93 (1998) 895-905
68. Szulc J., Wiznerowicz M., Sauvain M.O., Trono D., and Aebischer P. A versatile tool for conditional gene expression and knockdown. Nat Methods 3 (2006) 109-116
69. Thapar A., O'Donovan M., and Owen M.J. The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 14 (2005) R275-R282
70. Wade T.R., de Wit H., and Richards J.B. Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology 150 (2000) 90-101
71. Willcutt E.G., Doyle A.E., Nigg J.T., Faraone S.V., and Pennington B.F. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 57 (2005) 1336-1346
72. Zuckerman M., and Kuhlman D.M. Personality and risk-taking: Common biosocial factors. J Pers 68 (2000) 999-1029